Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Dilution correction for dynamically influenced urinary analyte data.

Hertel J, Rotter M, Frenzel S, Zacharias HU, Krumsiek J, Rathkolb B, Hrabe de Angelis M, Rabstein S, Pallapies D, Brüning T, Grabe HJ, Wang-Sattler R.

Anal Chim Acta. 2018 Nov 22;1032:18-31. doi: 10.1016/j.aca.2018.07.068. Epub 2018 Jul 28.

PMID:
30143216
2.

Night Shift Work Affects Urine Metabolite Profiles of Nurses with Early Chronotype.

Rotter M, Brandmaier S, Covic M, Burek K, Hertel J, Troll M, Bader E, Adam J, Prehn C, Rathkolb B, Hrabe de Angelis M, Grabe HJ, Daniel H, Kantermann T, Harth V, Illig T, Pallapies D, Behrens T, Brüning T, Adamski J, Lickert H, Rabstein S, Wang-Sattler R.

Metabolites. 2018 Aug 21;8(3). pii: E45. doi: 10.3390/metabo8030045.

3.

Vitamin D supply in shift working nurses.

Lehnert M, Beine A, Burek K, Putzke S, Schlösser S, Pallapies D, Brüning T, Behrens T, Rabstein S.

Chronobiol Int. 2018 May;35(5):724-729. doi: 10.1080/07420528.2018.1424719. Epub 2018 Apr 11.

PMID:
29641263
4.

Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history.

Cordina-Duverger E, Menegaux F, Popa A, Rabstein S, Harth V, Pesch B, Brüning T, Fritschi L, Glass DC, Heyworth JS, Erren TC, Castaño-Vinyals G, Papantoniou K, Espinosa A, Kogevinas M, Grundy A, Spinelli JJ, Aronson KJ, Guénel P.

Eur J Epidemiol. 2018 Apr;33(4):369-379. doi: 10.1007/s10654-018-0368-x. Epub 2018 Feb 20.

PMID:
29464445
5.

Shift work and the incidence of prostate cancer: a 10-year follow-up of a German population-based cohort study.

Behrens T, Rabstein S, Wichert K, Erbel R, Eisele L, Arendt M, Dragano N, Brüning T, Jöckel KH.

Scand J Work Environ Health. 2017 Nov 1;43(6):560-568. doi: 10.5271/sjweh.3666. Epub 2017 Sep 7.

PMID:
28879368
6.

Stability of targeted metabolite profiles of urine samples under different storage conditions.

Rotter M, Brandmaier S, Prehn C, Adam J, Rabstein S, Gawrych K, Brüning T, Illig T, Lickert H, Adamski J, Wang-Sattler R.

Metabolomics. 2017;13(1):4. Epub 2016 Nov 28.

7.

Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study.

Rabstein S, Harth V, Justenhoven C, Pesch B, Plöttner S, Heinze E, Lotz A, Baisch C, Schiffermann M, Brauch H, Hamann U, Ko Y, Brüning T; GENICA Consortium.

Chronobiol Int. 2014 Dec;31(10):1115-22. doi: 10.3109/07420528.2014.957301. Epub 2014 Sep 17.

PMID:
25229211
8.

N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.

Pesch B, Gawrych K, Rabstein S, Weiss T, Casjens S, Rihs HP, Ding H, Angerer J, Illig T, Klopp N, Bueno-de-Mesquita B, Ros MM, Kaaks R, Chang-Claude J, Roswall N, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Dossus L, Boeing H, Weikert S, Trichopoulos D, Palli D, Sieri S, Tumino R, Panico S, Quirós JR, González C, Sánchez MJ, Dorronsoro M, Navarro C, Barricarte A, Ljungberg B, Johansson M, Ulmert D, Ehrnström R, Khaw KT, Wareham N, Key TJ, Ferrari P, Romieu I, Riboli E, Brüning T, Vineis P.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2055-65. doi: 10.1158/1055-9965.EPI-13-0119-T. Epub 2013 Oct 3.

9.

CYP2B6*6 is associated with increased breast cancer risk.

Justenhoven C, Pentimalli D, Rabstein S, Harth V, Lotz A, Pesch B, Brüning T, Dörk T, Schürmann P, Bogdanova N, Park-Simon TW, Couch FJ, Olson JE, Fasching PA, Beckmann MW, Häberle L, Ekici A, Hall P, Czene K, Liu J, Li J, Baisch C, Hamann U, Ko YD, Brauch H.

Int J Cancer. 2014 Jan 15;134(2):426-30. doi: 10.1002/ijc.28356. Epub 2013 Jul 30.

10.

The UGT1A6_19_GG genotype is a breast cancer risk factor.

Justenhoven C, Obazee O, Winter S, Rabstein S, Lotz A, Harth V, Pesch B, Brüning T, Baisch C, Hartikainen JM, Mannermaa A, Kosma VM, Kataja V, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Fasching PA, Beckmann M, Ekici AB, Hein A, Hall P, Li J, Chang-Claude J, Flesch-Janys D, Seibold P, Rudolph A, Hamann U, Ko YD, Brauch H.

Front Genet. 2013 Jun 11;4:104. doi: 10.3389/fgene.2013.00104. eCollection 2013.

11.

Night work and breast cancer estrogen receptor status--results from the German GENICA study.

Rabstein S, Harth V, Pesch B, Pallapies D, Lotz A, Justenhoven C, Baisch C, Schiffermann M, Haas S, Fischer HP, Heinze E, Pierl C, Brauch H, Hamann U, Ko Y, Brüning T; GENICA Consortium.

Scand J Work Environ Health. 2013 Sep 1;39(5):448-55. doi: 10.5271/sjweh.3360. Epub 2013 Mar 29.

12.

Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant.

Obazee O, Justenhoven C, Winter S, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Hannelius U, Li J, Humphreys K, Hall P, Giles G, Severi G, Baglietto L, Southey M, Rabstein S, Harth V, Lotz A, Pesch B, Brüning T, Baisch C, Ko YD, Hamann U, Brauch H.

Breast Cancer Res Treat. 2013 Apr;138(2):543-8. doi: 10.1007/s10549-013-2448-7. Epub 2013 Feb 21.

PMID:
23430226
13.

Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases.

Bermejo JL, Kabisch M, Dünnebier T, Schnaidt S, Melchior F, Fischer HP, Harth V, Rabstein S, Pesch B, Brüning T, Justenhoven C, Brauch H, Baisch C, Ko YD, Hamann U.

Int J Cancer. 2013 Jul 15;133(2):362-72. doi: 10.1002/ijc.28040. Epub 2013 Feb 25.

14.

NOTCH1, HIF1A and other cancer-related proteins in lung tissue from uranium miners--variation by occupational exposure and subtype of lung cancer.

Pesch B, Casjens S, Stricker I, Westerwick D, Taeger D, Rabstein S, Wiethege T, Tannapfel A, Brüning T, Johnen G.

PLoS One. 2012;7(9):e45305. doi: 10.1371/journal.pone.0045305. Epub 2012 Sep 17.

15.

Light exposure and melatonin among rotating shift nurses--letter.

Rabstein S, Behrens T, Brüning T.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):557; author reply 558. doi: 10.1158/1055-9965.EPI-11-1081. Epub 2012 Feb 10. No abstract available.

16.

The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.

Justenhoven C, Obazee O, Winter S, Couch FJ, Olson JE, Hall P, Hannelius U, Li J, Humphreys K, Severi G, Giles G, Southey M, Baglietto L, Fasching PA, Beckmann MW, Ekici AB, Hamann U, Baisch C, Harth V, Rabstein S, Lotz A, Pesch B, Brüning T, Ko YD, Brauch H.

Breast Cancer Res Treat. 2012 Jan;131(1):347-50. doi: 10.1007/s10549-011-1827-1. Epub 2011 Oct 26. No abstract available.

PMID:
22037784
17.

The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans.

Lang T, Justenhoven C, Winter S, Baisch C, Hamann U, Harth V, Ko YD, Rabstein S, Spickenheuer A, Pesch B, Brüning T, Schwab M, Brauch H.

Breast Cancer Res Treat. 2011 Oct;129(3):993-9. doi: 10.1007/s10549-011-1613-0. Epub 2011 Jun 8.

PMID:
21655989
18.

No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk.

Dünnebier T, Schlaefer K, Gilbert M, Baisch C, Justenhoven C, Brauch H, Harth V, Spickenheuer A, Rabstein S, Pesch B, Brüning T, Ko YD, Hamann U.

Breast Cancer Res Treat. 2011 May;127(1):259-64. doi: 10.1007/s10549-010-1194-3. Epub 2010 Oct 9.

PMID:
20936341
19.

Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk.

Justenhoven C, Winter S, Dünnebier T, Hamann U, Baisch C, Rabstein S, Spickenheuer A, Harth V, Pesch B, Brüning T, Ko YD, Brauch H.

Breast Cancer Res Treat. 2010 Nov;124(1):289-92. doi: 10.1007/s10549-010-1093-7. Epub 2010 Aug 5. No abstract available.

PMID:
20686835
20.

Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.

Justenhoven C, Schaeffeler E, Winter S, Baisch C, Hamann U, Harth V, Rabstein S, Spickenheuer A, Pesch B, Brüning T, Ko YD, Schwab M, Brauch H.

Breast Cancer Res Treat. 2011 Jan;125(2):563-9. doi: 10.1007/s10549-010-1046-1. Epub 2010 Jul 16.

PMID:
20635135
21.

Night work and breast cancer - results from the German GENICA study.

Pesch B, Harth V, Rabstein S, Baisch C, Schiffermann M, Pallapies D, Bonberg N, Heinze E, Spickenheuer A, Justenhoven C, Brauch H, Hamann U, Ko Y, Straif K, Brüning T.

Scand J Work Environ Health. 2010 Mar;36(2):134-41. Epub 2009 Dec 29.

22.

N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer.

Rabstein S, Brüning T, Harth V, Fischer HP, Haas S, Weiss T, Spickenheuer A, Pierl C, Justenhoven C, Illig T, Vollmert C, Baisch C, Ko YD, Hamann U, Brauch H, Pesch B; GENICA Network.

Eur J Cancer Prev. 2010 Mar;19(2):100-9. doi: 10.1097/CEJ.0b013e328333fbb7.

PMID:
19996973
23.

No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk.

Andonova IE, Justenhoven C, Winter S, Hamann U, Baisch C, Rabstein S, Spickenheuer A, Harth V, Pesch B, Brüning T, Ko YD, Ganev V, Brauch H.

Breast Cancer Res Treat. 2010 Jun;121(2):497-502. doi: 10.1007/s10549-009-0589-5. Epub 2009 Oct 27.

PMID:
19859803
24.

Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.

Dünnebier T, Bermejo JL, Haas S, Fischer HP, Pierl CB, Justenhoven C, Brauch H, Baisch C, Gilbert M, Harth V, Spickenheuer A, Rabstein S, Pesch B, Brüning T, Ko YD, Hamann U.

Breast Cancer Res Treat. 2010 May;121(1):185-94. doi: 10.1007/s10549-009-0530-y. Epub 2009 Sep 17.

PMID:
19760037
25.

Comparison of wheat and rye flour solutions for skin prick testing: a multi-centre study (Stad 1).

van Kampen V, Merget R, Rabstein S, Sander I, Bruening T, Broding HC, Keller C, Muesken H, Overlack A, Schultze-Werninghaus G, Walusiak J, Raulf-Heimsoth M.

Clin Exp Allergy. 2009 Dec;39(12):1896-902. doi: 10.1111/j.1365-2222.2009.03342.x. Epub 2009 Aug 25.

PMID:
19709069
26.

Occupational exposure to polycyclic aromatic hydrocarbons and DNA damage by industry: a nationwide study in Germany.

Marczynski B, Pesch B, Wilhelm M, Rossbach B, Preuss R, Hahn JU, Rabstein S, Raulf-Heimsoth M, Seidel A, Rihs HP, Adams A, Scherenberg M, Erkes A, Engelhardt B, Straif K, Käfferlein HU, Angerer J, Brüning T.

Arch Toxicol. 2009 Oct;83(10):947-57. doi: 10.1007/s00204-009-0444-9. Epub 2009 Jun 19.

PMID:
19543712
27.

Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.

Dünnebier T, Bermejo JL, Haas S, Fischer HP, Pierl CB, Justenhoven C, Brauch H, Baisch C, Gilbert M, Harth V, Spickenheuer A, Rabstein S, Pesch B, Brüning T, Ko YD, Hamann U.

Int J Cancer. 2009 Aug 1;125(3):596-602. doi: 10.1002/ijc.24286.

28.

Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers.

Haas S, Gevensleben H, Rabstein S, Harth V, Pesch B, Brüning T, Justenhoven C, Brauch H, Hamann U, Ko YD, Baisch C, Fischer HP, Büttner R.

Oncol Rep. 2009 Feb;21(2):299-304.

PMID:
19148499
29.

Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.

Justenhoven C, Pierl CB, Haas S, Fischer HP, Hamann U, Baisch C, Harth V, Spickenheuer A, Rabstein S, Vollmert C, Illig T, Pesch B, Brüning T, Dippon J, Ko YD, Brauch H.

Int J Cancer. 2009 May 1;124(9):2077-81. doi: 10.1002/ijc.24198.

30.

Prediction of challenge test results by flour-specific IgE and skin prick test in symptomatic bakers.

van Kampen V, Rabstein S, Sander I, Merget R, Brüning T, Broding HC, Keller C, Müsken H, Overlack A, Schultze-Werninghaus G, Walusiak J, Raulf-Heimsoth M.

Allergy. 2008 Jul;63(7):897-902. doi: 10.1111/j.1398-9995.2008.01646.x.

PMID:
18588556
31.

Rapid detection of the hOGG1 Ser326Cys polymorphism using LightCycler technology.

Rihs HP, Marczynski B, Rabstein S, Scherenberg M, Landt O, Bruning T.

J Toxicol Environ Health A. 2008;71(13-14):877-80. doi: 10.1080/15287390801988038.

PMID:
18569589
32.

Association between genetic polymorphisms in styrene-metabolizing enzymes and biomarkers in styrene-exposed workers.

Rihs HP, Triebig G, Werner P, Rabstein S, Heinze E, Pesch B, Bruning T.

J Toxicol Environ Health A. 2008;71(13-14):866-73. doi: 10.1080/15287390801987998.

PMID:
18569587
33.

Lack of association of delta-aminolevulinate dehydratase polymorphisms with blood lead levels and hemoglobin in Romanian women from a lead-contaminated region.

Rabstein S, Unfried K, Ranft U, Illig T, Kolz M, Mambetova C, Vlad M, Roman C, Weiss T, Becker D, Brüning T, Pesch B.

J Toxicol Environ Health A. 2008;71(11-12):716-24. doi: 10.1080/15287390801985190.

PMID:
18569569
34.

CYP2C19*17 is associated with decreased breast cancer risk.

Justenhoven C, Hamann U, Pierl CB, Baisch C, Harth V, Rabstein S, Spickenheuer A, Pesch B, Brüning T, Winter S, Ko YD, Brauch H.

Breast Cancer Res Treat. 2009 May;115(2):391-6. doi: 10.1007/s10549-008-0076-4. Epub 2008 Jun 3.

PMID:
18521743
35.

[Typical bacteria in an intensive care burn unit in severely burned patients and their importance with regard to mortality: retrospective study 1995 - 2004].

Steinsträsser L, Thies AH, Rabstein S, Steinau HU.

Handchir Mikrochir Plast Chir. 2007 Oct;39(5):338-44. German.

PMID:
17985278
36.

Dose-response modeling of occupational exposure to polycyclic aromatic hydrocarbons with biomarkers of exposure and effect.

Pesch B, Kappler M, Straif K, Marczynski B, Preuss R, Rossbach B, Rihs HP, Weiss T, Rabstein S, Pierl C, Scherenberg M, Adams A, Käfferlein HU, Angerer J, Wilhelm M, Seidel A, Brüning T.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1863-73. Erratum in: Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2519.

37.

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H.

Breast Cancer Res Treat. 2008 Mar;108(1):137-49. Epub 2007 Jun 23.

PMID:
17588204
38.

Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas.

Haas S, Pierl C, Harth V, Pesch B, Rabstein S, Brüning T, Ko Y, Hamann U, Justenhoven C, Brauch H, Fischer HP.

Int J Cancer. 2006 Oct 15;119(8):1785-91.

39.

Variation of the N-acetyltransferase 2 gene in a Romanian and a Kyrgyz population.

Rabstein S, Unfried K, Ranft U, Illig T, Kolz M, Rihs HP, Mambetova C, Vlad M, Brüning T, Pesch B.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):138-41.

40.

One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany.

Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, Baisch C, Vollmert C, Illig T, Brüning T, Ko Y, Brauch H.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):3015-8. No abstract available.

41.

Factors modifying the association between hormone-replacement therapy and breast cancer risk.

Pesch B, Ko Y, Brauch H, Hamann U, Harth V, Rabstein S, Pierl C, Fischer HP, Baisch C, Justenhoven C, Ranft U, Brüning T.

Eur J Epidemiol. 2005;20(8):699-711.

PMID:
16151884
42.

Occupational exposure to polycyclic aromatic hydrocarbons in German industries: association between exogenous exposure and urinary metabolites and its modulation by enzyme polymorphisms.

Rihs HP, Pesch B, Kappler M, Rabstein S, Rossbach B, Angerer J, Scherenberg M, Adams A, Wilhelm M, Seidel A, Brüning T.

Toxicol Lett. 2005 Jul 4;157(3):241-55. Epub 2005 Apr 8.

PMID:
15917149
43.

Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer.

Abraham BK, Justenhoven C, Pesch B, Harth V, Weirich G, Baisch C, Rabstein S, Ko YD, Brüning T, Fischer HP, Haas S, Brod S, Oberkanins C, Hamann U, Brauch H; GENICA Network.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1102-7.

44.

DNA strand breaks in the lymphocytes of workers exposed to diisocyanates: indications of individual differences in susceptibility after low-dose and short-term exposure.

Marczynski B, Merget R, Mensing T, Rabstein S, Kappler M, Bracht A, Haufs MG, Käfferlein HU, Brüning T.

Arch Toxicol. 2005 Jun;79(6):355-62. Epub 2005 Feb 3.

PMID:
15690151
45.

[Tenosynovial giant cell tumor].

Kuhnen C, Müller KM, Rabstein S, Kasprzynski A, Herter P.

Pathologe. 2005 Mar;26(2):96-110. German.

PMID:
15657685
46.

[Desmoid-type fibromatosis (aggressive fibromatosis)].

Kuhnen C, Helwing M, Rabstein S, Homann HH, Müller KM.

Pathologe. 2005 Mar;26(2):117-26. German.

PMID:
15657684
47.

ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.

Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Brüning T, Brauch H.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2059-64.

48.

VHL mutations in renal cell cancer: does occupational exposure to trichloroethylene make a difference?

Brauch H, Weirich G, Klein B, Rabstein S, Bolt HM, Brüning T.

Toxicol Lett. 2004 Jun 15;151(1):301-10.

PMID:
15177666
49.

Polymorphic metabolic susceptibility genes and longevity: a study in octogonarians.

Pesch B, Düsing R, Rabstein S, Harth V, Grentrup D, Brüning T, Landt O, Vetter H, Ko YD.

Toxicol Lett. 2004 Jun 15;151(1):283-90.

PMID:
15177664
50.

Changes in low molecular weight DNA fragmentation in white blood cells after diisocyanate exposure of workers.

Marczynski B, Merget R, Teschner B, Korn M, Rabstein S, Brüning T.

Arch Toxicol. 2003 Aug;77(8):470-6. Epub 2003 Apr 24.

PMID:
12712233

Supplemental Content

Loading ...
Support Center